High Tumor Mutational Burden May Predict Improved Response to Immunotherapy in Head and Neck Cancer Patients

被引：0
|
作者：
Stewart, M. [1 ]
Reddy, C. A. [2 ]
Woody, N. M. [2 ]
Sussman, T. [3 ]
Yilmaz, E. [1 ]
Geiger, J. L. [1 ]
机构：
[1] Cleveland Clin, Taussig Canc Ctr, Dept Hematol & Med Oncol, Cleveland, OH 44106 USA
[2] Cleveland Clin, Taussig Canc Inst, Dept Radiat Oncol, Cleveland, OH 44106 USA
[3] Cleveland Clin, Taussig Canc Inst, Dept Hematol Oncol, Cleveland, OH 44106 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 118卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
162
引用
收藏
页码：E43 / E43
页数：1
相关论文
共 50 条
  • [31] Immunostimulatory Cancer-Associated Fibroblast Subpopulations Can Predict Immunotherapy Response in Head and Neck Cancer
    Obradovic, Aleksandar
    Graves, Diana
    Korrer, Michael
    Wang, Yu
    Roy, Sohini
    Naveed, Abdullah
    Xu, Yaomin
    Luginbuhl, Adam
    Curry, Joseph
    Gibson, Michael
    Idrees, Kamran
    Hurley, Paula
    Jiang, Peng
    Liu, X. Shirley
    Uppaluri, Ravindra
    Drake, Charles G.
    Califano, Andrea
    Kim, Young J.
    CLINICAL CANCER RESEARCH, 2022, 28 (10) : 2094 - 2109
  • [32] IMMUNOTHERAPY IN PATIENTS WITH HEAD AND NECK-CANCER
    VINZENZ, K
    MICKSCHE, M
    INTERNATIONAL JOURNAL OF IMMUNOTHERAPY, 1986, 2 (01): : 37 - 49
  • [33] Using a Recently Approved Tumor Mutational Burden Biomarker to Stratify Patients for Immunotherapy May Introduce a Sex Bias
    Sinha, Neelam
    Sinha, Sanju
    Cheng, Kuoyuan
    Madan, Sanna
    Erez, Ayelet
    Ryan, Brid M.
    Schaffer, Alejandro A.
    Aldape, Kenneth
    Eytan, Ruppin
    JCO PRECISION ONCOLOGY, 2021, 5 : 1147 - 1150
  • [34] High dimensional immuno-phenotyping of immunotherapy response in head and neck cancer
    O'Byrne, K. J.
    Ma, N.
    Sadeghirad, H.
    Jhaveri, N.
    Monkman, J.
    Pratapa, A.
    Cheikh, B. Ben
    Ladwa, R.
    Hughes, B. G. M.
    Braubach, O.
    Kulasinghe, A.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S841 - S841
  • [35] Treatment response lowers tumor symptom burden in recurrent and/or metastatic head and neck cancer
    Hecht, Markus
    Hahn, Dennis
    Wolber, Philipp
    Hautmann, Matthias G.
    Reichert, Dietmar
    Weniger, Steffi
    Belka, Claus
    Bergmann, Tobias
    Goehler, Thomas
    Welslau, Manfred
    Grosse-Thie, Christina
    Guntinas-Lichius, Orlando
    von der Gruen, Jens
    Balermpas, Panagiotis
    Orlowski, Katrin
    Messinger, Diethelm
    Stenzel, Karsten G.
    Fietkau, Rainer
    BMC CANCER, 2020, 20 (01)
  • [36] Treatment response lowers tumor symptom burden in recurrent and/or metastatic head and neck cancer
    Markus Hecht
    Dennis Hahn
    Philipp Wolber
    Matthias G. Hautmann
    Dietmar Reichert
    Steffi Weniger
    Claus Belka
    Tobias Bergmann
    Thomas Göhler
    Manfred Welslau
    Christina Große-Thie
    Orlando Guntinas-Lichius
    Jens von der Grün
    Panagiotis Balermpas
    Katrin Orlowski
    Diethelm Messinger
    Karsten G. Stenzel
    Rainer Fietkau
    BMC Cancer, 20
  • [37] Case Report: Sequential Chemotherapy and Immunotherapy Produce Sustained Response in Osteosarcoma With High Tumor Mutational Burden
    Zheng, Shuier
    Wang, Fenglin
    Huang, Jin
    Zhou, Yan
    Yang, Quanjun
    Qian, Guowei
    Zhou, Chenliang
    Min, Daliu
    Song, Lele
    Shen, Zan
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [38] Lung Cancer with a High Tumor Mutational Burden REPLY
    Gandhi, Leena
    Garassino, Marina C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (11):
  • [39] MicroRNAs Expression Patterns Predict Tumor Mutational Burden in Colorectal Cancer
    Huang, Jiahao
    Liu, Haizhou
    Zhao, Yang
    Luo, Tao
    Liu, Jungang
    Liu, Junjie
    Pan, Xiaoyan
    Tang, Weizhong
    FRONTIERS IN ONCOLOGY, 2021, 10
  • [40] Hot or Not: Tumor Mutational Burden (TMB) as a Biomarker of Immunotherapy Response in Genitourinary Cancers
    Halbert, Brian
    Einstein, David J.
    UROLOGY, 2021, 147 : 119 - 126
12345